Lab Supplies: Turning an Undermanaged Category into a Key Valu...
Lab supplies are one of biopharma's last undermanaged spend categories. Fragmented procurement slows research, creates supply risks, and limits savings. For CPOs, CEOs, and CFOs, this is a financial and innovation performance issue.
Winning the capacity race: From demand planning to supplier co...
Energy infrastructure demand is outpacing supplier capacity. Learn how utilities and developers can move beyond price-led procurement, secure scarce capacity earlier and protect project delivery through credible, multi-year commitments.
Indirect spend tops 20% of turnover for most fashion companies, yet few govern it well. The Inverto Fashion Study 2026 reveals the execution gap holding margins back, and what leading procurement teams do differently. Download the full results.
The Raw Materials Study 2026 provides insights into how companies are responding to rising raw material risks. Explore the latest findings and discover the priorities shaping resilient sourcing, procurement, and AI adoption.
CPOs fear the wrong AI risk. The real threat is not a failed pilot. It is deploying agents on processes that were never clearly defined. How procurement leaders redirect that anxiety into process clarity, smarter pilots, and scalable impact.
The Hidden Upside in Pharma and Medtech Marketing Media Spend
Marketing media remains one of the least transparent spend categories in pharma and medtech. Learn how greater transparency, structured sourcing, and cross functional collaboration help organizations gain control, unlock value, and strengthen marketi...
Most procurement teams have visibility but few have control. AI Spend Guard shifts the governance model from retrospective reporting to real-time decision support, at the moment purchases are made.
Rapid Rebound: Delivering Impact Across Three Horizons
Industrial goods companies face growing pressure on margins, cash, and competitiveness. Rapid Rebound provides a structured approach to generate immediate impact while building long-term resilience.
The Bill of Materials as a Profit Engine: How Companies Unlock...
The Bill of Materials has become a strategic profit lever. Discover how integrating engineering, procurement and AI helps executives unlock 5–12% cost savings while strengthening margins and competitiveness.
Pharma Procurement: Achieving the Next Efficiency Leap in Cost...
Cost excellence has become a strategic imperative in pharma. Discover how leading organizations unlock sustainable savings across direct and indirect spend, and why AI-driven changes in supplier cost structures create new procurement opportunities.
